Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CORSYM

CHLORPHENIRAMINE POLISTIREX; PHENYLPROPANOLAMINE POLISTIREX

Standard Dose
EQ 4MG MALEATE/5ML;EQ 37.5MG HCL/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CORSYM is listed in Drugs@FDA under application 018050 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CHLORPHENIRAMINE POLISTIREX; PHENYLPROPANOLAMINE POLISTIREX Form and strength SUSPENSION, EXTENDED RELEASE;ORAL - EQ 4MG MALEATE/5ML;EQ 37.5MG HCL/5ML Sponsor UCB INC Submission history Latest submission status date: 1988-04-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview CORSYM is listed in Drugs@FDA under application 018050 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CHLORPHENIRAMINE POLISTIREX; PHENYLPROPANOLAMINE POLISTIREX Form and strength SUSPENSION, EXTENDED RELEASE;ORAL - EQ 4MG MALEATE/5ML;EQ 37.5MG HCL/5ML Sponsor UCB INC Submission history Latest submission status date: 1988-04-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.